Received May 12, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 2 | Y013818 | IM / LA |
| MNQ | MENINGOCOCCAL CONJUGATE (MENQUADFI) | SANOFI PASTEUR | 1 | U8600AA | IM / RA |
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | Y013818 | OT / LA |
| MEN | MENINGOCOCCAL (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | 48600AA | OT / GM |
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | 2 | Y013818 | OT / RA |
No adverse event; Improper storage of product in use; This spontaneous report was received from a Other health professional and refers to a 13-year-old female patient. The patient's medical history was not reported. The patient's concurrent conditions were not reported. Historical drugs included Gardasil 9 (HPV vaccine VLP rL1 9v (yeast)). Concomitant medications included Menquadfi (Meningococcal vaccine A/C/Y/W conj (tet tox)). The vaccine Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL9) (lot #Y013818, expiration date: 12-Feb-2027) was improperly stored (47.4 F for 1 hour and 28.9 F for 45 minutes on 04-FEB-2026). On 16-Feb-2026, the patient was vaccinated with the second dose of this vaccine, 1 dosage form administered by Intramuscular route in Right Arm for Prophylaxis (Product storage error). No additional AE/No PQC reported. This case was received from the same reporter with the case US-009507513-2395843.
MenQuadfi